Отправить статью
EN
Адрес для писем
220006, г. Минск, ул. Ленинградская 6, кабинет 2
Телефон: +375 17 363-88-92
Эл.почта: medjournal@bsmu.by
  • Главная
  • Выпуски
  • 2016 №2
  • Нейрогуморальные маркеры кардиоваскулярного риска у лиц с синдромом обструктивного апноэ во сне

Нейрогуморальные маркеры кардиоваскулярного риска у лиц с синдромом обструктивного апноэ во сне

Е.К. Юшкевич, Н.П. Митьковская, Е.А. Григоренко, И.В. Патеюк УО «Белорусский государственный медицинский университет»
2016 №2 | Лекции
Аннотация
Список литературы
Скачать полнотекстовую статью
Синдром обструктивного апноэ во сне широко распространен в популяции и ассоциируется с повышенным риском развития ряда сердечно-сосудистых заболеваний. Однако основные нейрогуморальные процессы, опосредующие их взаимосвязь окончательно не определены.
Ключевые слова:
синдром обструктивного апноэ во сне, сердечно-сосудистый риск, храп, СПАП-терапия
Neurohumoral markers of cardiovascular rist in the patients wits obstructive sleep apnea syndrome

Obstructive sleep apnea is highly prevalent in the population and is associated with an increased risk of a number of cardiovascular diseases. Nowever, the basic processes of neurohumoral mediating their relationship are not finally determined.

Keywords
obstructive sleep apnea syndrome, cardiovascular risk, snoring, CPAP-therapy
  • 1. Литвин, А. Ю., Чазова И. Е. Синдром обструктивного апноэ во время сна: механизмы возникновения, клиническое значение, связь с сердечно – сосудистыми заболеваниями, принципы лечения // Кадиологический вестник. – 2009. – Т. IV, № 2. – С. 89–103.
  • 2. Митьковская, Н. П., Григоренко Е. А., Лазарь Е. А., Пинчук А. Ф. Клиническая характеристика синдрома обструктивного апноэ сна как фактора риска ишемической болезни сердца // Военная медицина. 2013. № 1. – С. 127–133.
  • 3. Arzt, M., Young T., Finn L., Skatrud J. B., Bradley T. D. Association of sleep-disordered breathing and the occurrence of stroke // The American Journal of Respiratory and Critical Care Medicine, 2005 Dec 1; Vol. 172(11). – P. 1447–51.
  • 4. Bakker, J. P., Weng J., Wang R., Redline S., Punjabi N. M., Patel S. R. Associations between Obstructive Sleep Apnea, Sleep Duration, and Abnormal Fasting Glucose. The Multi-Ethnic Study of Atherosclerosis // The American Journal of Respiratory and Critical Care Medicine. – 2015 Sep. 15; Vol. 192(6). – P. 745–53.
  • 5. Celec, P., Hodosy J., Behuliak M. et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure // Sleep and Breathing. – 2012. – Vol. 16, № 2. – P. 393–398.
  • 6. Chen, M., Wu B., Ye X., Zhou Z., Yue X., Wang Q., Wang W., Jiang Y., Lian X., Chen Z., Xu G., Liu X. J. Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemicstroke // Journal of Clinical Neuroscience. – 2011 Nov. – Vol. 18(11). – P. 1454–7.
  • 7. Chien, M. Y., Lee P., Tsai Y. F., Yang P. C., Wu Y. T. C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea // Sleep Breath. – 2012. – Vol. 16. – P. 629–37.
  • 8. Ciftci, T. U., Kokturk O., Bukan N., Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. – 2004 Oct. – Vol. 21. (2). – P. 87–91.
  • 9. Cofta, S., Wysocka E., Dziegielewska-Gesiaketal S. Plasma selectins in patients with obstructive sleep apnea // Advances in Experimental Medicine and Biology. – 2013. – Vol. 756. – P. 113–119.
  • 10. Gjørup, P. H., Sadauskiene L., Wessels J., Nyvad O., Strunge B. and Pedersen E. B. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease 1 // The American Journal of Hypertension. – 2007. – Vol. 20, № 1. – P. 44–52.
  • 11. Gottlieb, D. J., Yenokyan G., Newman A. B., O’Connor G. T., Punjabi N. M., Quan S. F., Redline S., Resnick H. E., Tong E. K., Diener-West M., Shahar E. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study // Circulation. – 2010 Jul. 27. – Vol. 122(4). – P. 352–60.
  • 12. Gottlieb, D. J. The Sleep Heart Health Study: a progress report // Current Opinion in Pulmonary Medicine – Medscape. – 2008 Nov. – Vol. 14(6). – P. 537–42.
  • 13. Grimpen, F., Kanne P., Schulz E., Hagenah G., Hasenfuß G., Andreas S. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea // European Respiratory Journal. – 2000. – Vol. 15, № 2. – P. 320–325.
  • 14. Halcox, J. P. J., Donald A. E., Ellins E. et al. Endothelial function predicts progression of carotid intima-media thickness // Circulation. – 2009. – Vol. 119(7). – P. 1005–1012.
  • 15. Jennum, P., Soul A. Epidemiology of snoring and obstructive sleep apnea in a Danish population age 30–60 // Journal of Sleep Research. – 1992. – Vol. 1. – P. 240–244.
  • 16. Kaneko, Y., Hajek V. E., Zivanovic V., Raboud J., Bradley T. D. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke // Sleep. – 2003. – Vol. 26(3). – P. 293–297.
  • 17. Kent, B. D., McNicholas W. T., Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea // Journal of Thoracic Disease. – 2015 Aug; Vol. 7(8). – P. 1343–57.
  • 18. Lavie, L., Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link // European Respiratory Journal. – 2009. – Vol. 33(6). – P. 1467–84.
  • 19. Liu, Z., Xu Y., Hua Q., Wang Y., Liu R., Yang Z. Additive effects of obstructive sleep apnea syndrome and hypertension on inflammatory reaction // African Journal Biotechnology. – 2011. – Vol. 10. – P. 11738–44.
  • 20. Malakasioti, G., Alexopoulos E., Befani C. et al. Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA // Sleep and Breathing. – 2012. – Vol. 16, № 3. – P. 703–708.
  • 21. Marin. J. M., Carrizo S. J., Vicente E., Agusti A. G. N.. Longterm cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study // The Lancet. – 2005. – Vol. 365(9464). – P. 1046–1053.
  • 22. Mehra, R., Storfer-Isser A., Kirchner H. L. et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder // Archives of Internal Medicine Journal. – 2006. – Vol. 166. – P. 1725–31.
  • 23. Niu, X., Chen X., Xiao Y., Dong J., Zhang R., Lu M., Kong W. The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis... PLoS One. 2014 Apr 25. Vol. 9(4).
  • 24. Parati, G., Lombardi C., Hedner J., Bonsignore M. R., Grote L., Tkacova R., Lévy P., Riha R., Bassetti C., Narkiewicz K., Mancia G., McNicholas W. T. Recommendations for the management of patients with obstructive sleep apnoe and hypertension // The European Respiratory Journal. – 2013 Mar. – Vol. 41(3). – P. 523–38.
  • 25. Peker, Y., Carlson J., Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long–term follow–up // European Respiratory Jornal. – 2006. – Vol. 28. – P. 596–602.
  • 26. Peker, Y., Hedner J., Kraiczi H., Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease // The American Journal of Respiratory and Critical Care Medicine. 2000 Jul. – Vol. 162(1). – P. 81–6.
  • 27. Phillips, B. G., Narkiewicz K., Pesek C. A., Haynes W. G., Dyken M. E. and Somers V. K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure // Journal of Hypertension. – 1999. – Vol. 17, № 1. – P. 61–66.
  • 28. Pilkauskaite, G., Miliauskas S., Vitkauskiene A., Sakalauskas R. Vascular adhesion molecules in men with obstructive sleep apnea: associations with obesity and metabolicsyndrome // Sleep Breath. – 2014 Dec. – Vol. 18(4). – P. 869–74.
  • 29. Pratt-Ubunama, M. N., Nishizaka M. K., Boedefeld R. L., Cofield S. S., Harding S. M., Calhoun D. A . Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension // Chest. – 2007 Feb. – Vol. 131(2). – P. 453–9.
  • 30. Priou, P., Gagnadoux F., Tesse A. et al. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea // The American Journal of Pathology. – 2010. – Vol. 177. – P. 974–83.
  • 31. Rajagopalan, N. Obstructive sleep apnea: not just a sleep disorder // Journal of Postgraduate Medical. – 2011 Apr–Jun. – Vol. 57(2). – P. 168–75.
  • 32. Redline, S., Yenokyan G., Gottlieb D. J. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study // American Journal of Respiratory and Critical Care Medicine. – 2010. – Vol. 182(2). – P. 269–277.
  • 33. Ryan, S., Nolan G. M., Hannigan E., Cunningham S., Taylor C., McNicholas W. T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. // Thorax. – 2007. – Vol. 62. – P. 509–14.
  • 34. Ryan, S., Taylor C. T., McNicholas W. T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome // Circulation. – 2005 Oct. 25. – Vol. 112(17). – P. 2660–7.
  • 35. Ryan, S., Taylor C. T., McNicholas W. T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? // Thorax. – 2009. – Vol. 64. – P 631–636.
  • 36. Saarelainen, S., Hasan J. Circulating endothelin-1 and obstructive sleep apnoea // European Respiratory Journal. – 2000. – Vol. 16, № 4. – P. 794–795.
  • 37. Shahar, E., Whitney C. W., Redline S., Lee E. T., Newman A. B., Javier Nieto F., O’Connor G. T., Boland L. L., Schwartz J. E., Samet J. M. Sleep-disordered breathing and cardiovascular disease: crosssectional results of the Sleep Heart Health Study // The American Journal of Respiratory and Critical Care Medicine. – 2001. – Vol. 163. – P. 19–25.
  • 38. Sorajja, D., Gami A. S., Somers V. K., Behrenbeck T. R., Garcia-Touchard A., Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease // Chest. – 2008. – Vol. 133(4). – P. 927–933.
  • 39. Steiropoulos, P., Tsara V., Nena E., Fitili C., Kataropoulou M., Froudarakis M., Christaki P., Bouros D. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome // Chest. – 2007 Sep. – Vol. 132(3). – P. 843–51.
  • 40. Yamauchi, M., Nakano H., Maekawa J. et al. Oxidative stress in obstructive sleep apnea // Chest. – 2005. – Vol. 127(5). – P. 1674–1679.